Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106 USD | -1.21% | -1.51% | -3.72% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.72% | 186B | |
-2.60% | 107B | |
-3.79% | 67.44B | |
+2.66% | 50.03B | |
+16.39% | 47.81B | |
+4.00% | 41.03B | |
+1.38% | 26.85B | |
+1.52% | 25.82B | |
-1.17% | 25.01B | |
+14.17% | 24.74B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- BTIG Lowers Abbott Laboratories' Price Target to $126 From $130, Maintains Buy Rating